C
Description
Listed biopharmaceutical company specialising in fermentation-based and semi-synthetic active pharmaceutical ingredients, with a growing finished formulations business. Three plants in Gujarat: Dholka and Limbasi for APIs, with 1,250 cubic metres of fermentation capacity, and Valthera for formulation. Manufactures twenty-three APIs across immunosuppressants — tacrolimus, mycophenolate, cyclosporine, sirolimus — oncology and anti-infectives. Sells in more than seventy countries.